Probiotics: Clinical perspectives;Probióticos: Utilidad clínica

Colombia Medica

Volumn 37, Issue 4, 2006, Pages 308-314

  Castro, Luz Ángela ^a   de Rovetto, Consuelo ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Allergies; Diarrhea; Enterocolitis; Probiotics; Urinary infection; Vaginosis

Indexed keywords

ANTIBIOTIC AGENT; BIFIDOLAC; EPTAVIS; FLORATIL; PLACEBO; PROBIOTIC AGENT; VACCINE;

ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CANCER; CANCER PREVENTION; CARCINOGENESIS; CLINICAL STUDY; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG USE; ENTERITIS; ENTEROCOCCUS CASSELIFLAVUS; FOOD ALLERGY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTIOUS DIARRHEA; INGESTION; INTESTINE FUNCTION; IRRITABLE COLON; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOSE INTOLERANCE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PROPHYLAXIS; ROTAVIRUS; SACCHAROMYCES BOULARDII; SAFETY; STREPTOCOCCUS SALIVARIUS; TRAVELLER DIARRHEA; TREATMENT FAILURE; URINARY TRACT INFECTION; VACCINE PRODUCTION; VAGINITIS; VIRUS INFECTION;

EID: 33845188901     PISSN: 16579534     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Young RJ, Huffmans S. Probiotic use in children. J Pedriatr Health Care 2003; 17: 277-283.
2. González BE, Treviño M, Jiménez Z. Bacteriocinas de probióticos. RESPYN 2003; 4: 99-106.
3. Dunne C, O'Mahony L, Murphy E, Thornton G, Morrissey D, O'Halloran S, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001; 73 (Suppl): 386-392.
4. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16: 658-672.
5. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130: 396-402.
6. Gorbach SI. Probiotics in the third millennium. Dig Liver Dis 2002; 34 (Suppl): 2-7.
7. Schrezenmeir J, De Vress M. Probiotics, prebiotics and symbiotic-approaching a definition. Am J Clin Nutr 2001; 73 (Suppl): 361-364.
8. Ruiz D, Calderón L, Sánchez JT, Tay J. Intestinal candidiasis. A clinical report and comments about this opportunistic pathology. Mycopathologia 2002; 156: 9-11.
9. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 200; 73 (Suppl): 444-450.
10. Warner RD, Warner T, Pierson C, Roberts L, Farmer J, Dohnalek M, et al. Biotherapeutic effects of Bifidobacterium spp on orogastric and systemic candidiasis in immunodeficient mice.Rev Iberoam Micol 1998; 15: 265-270.
11. Warner RD, Warner T, Roberts L, Farmer J, Dohnalek M, Hilty M, et al. Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunodeficient mice. Rev Iberoam Micol 1998; 15: 271-276.
12. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Keppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-395.
13. Goossens D, Jonkers D, Stobberingh E, van den Bogaard A, Russel M, Stockbrügger R. Probiotics in gastroenterology: indications and future perspectives. Scan J Gastroenterol 2003; 239 (Suppl): 15-23.
14. Elmer GW. Probiotics: 'Living drugs'. Am J Health Syst Pharm 2001; 58: 1101-1109.
15. Cremonini F, Di Caro S, Vista EC, Bartolozzi F, Capelli G, Gasbarrini B, et al. Meta-analysis: The effect of probiotic administration on antibiotic associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461-1467.
16. D'Souza AL, Rajkumar CH, Cooke J, Bulpitt CHJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.BMJ 2002; 321: 1-6.
17. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005; 21: 44-50.
18. Szajewska H, Mrukowiez J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr 2001; 33 (Suppl): 17-25.
19. Vanderhoof JA. Probiotics: future directions.Am J Clin Nut2001; 73 (Suppl): 1152-1155.
20. Shornikova AV, Casas IA, Isaolauri E, Mykkanen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhoea in young children. J Pediat Gastroenterol Nuts 1997; 24: 399-404.
21. Szajewka H, Kotowska M, Mrukowicz JE, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus sp. Strain GG in prevention of nosocomial diarrhoea in infants. J Pediatr 2001; 138: 361-365.
22. Guandalini S, Pensabene M, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30: 54-60.
23. Hilton E, Kolakowski P, Smith M, Singer C. Efficacy of Lactobacillus GG as a diarrhea preventative in traveler's. J Travel Med 1997; 4:41-43.
24. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, et al. Prevention of traveller's diarrhea by Lactobacillus GG. Ann Med 1990; 22: 53-56.
25. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114.
26. Hung-Chih L, Bai-Horng S, An-Chyi Ch, Tsung-Wen L, Chang-Hai T, Tsu-Fuh Y, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
27. Siu-Yin Ch, Kwong-Leung Ch. Pathogenesis of neonatal necrotizing enterocolitis. Ann Coll Surg HK 2001; 5: 52-54.
28. Llanos A, Mena P, Uauy R. Tendencias actuales en la nutrición del recién nacido prematuro. Rev Chil Pediatr 2004; 75:107-121.
29. Hoyos A. Reduced incidence of necrotizing enterocolitis associated with enteral adminstration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3: 197-202.
30. Forero J, Alarcón J, Cassalett G. Cuidado intensivo pediátrico y neonatal. Capítulo 9; Bogotá: 2005. p. 614-619.
31. Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites and the hygiene hypothesis. Science 2002; 296: 490-494.
32. Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infections. Int J Antimicrob Agents 2003; 22: 360-366.
33. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskenen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-1079.
34. Reid G, Devillard E. Probiotics for mother and child. J Clin Gastroenterol 2004; 38: 94-101.
35. Stapleton A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am 2003; 17: 693-700.
36. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor.Am J Obstet Gynecol 2003; 189: 1202-1208.
37. Grangette C, Müller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun 2001; 69: 1547-1553.
38. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, et al. Demonstration of safety of probiotics: a review. Int J Food Microbiol 1998; 44: 93-106.
39. Adams MR, Marteau P. On the safety of lactic acid bacteria from food. Int J Food Microbiol 1995; 27: 263-264.
40. Reid G. Safety of Lactobacillus strains as probiotic agents. Clin Infect Dis 2002; 35: 349-350.
41. Marteau P, Seksik P. Tolerance of probiotics and prebiotics.J Clin Gastroenterol 2004; 38 (Suppl): 67-69.
42. Lestin F, Pertschy A, Rimek D. Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities. Dtsch Med Wochenschr 2003; 28: 2531-2533.
43. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infec Dis 2002; 35: 1155-1160.